Crossmark

Appropriate Number of Adjuvant Chemotherapy Cycles for Patients with Stage 2 or 3 Gastric Cancer After Curative Gastrectomy: A Multicenter Cohort Study

Crossref DOI link: https://doi.org/10.1245/s10434-020-09504-4

Published Online: 2021-01-10

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jeong, Sang-Ho https://orcid.org/0000-0001-9061-6236
Yoo, Moon-Won

Son, Young-Gil

Oh, Sung Jin

Kim, Jong-Han

Kim, Hyoung-Il

Park, Joong-Min

Hur, Hoon

Jee, Ye Seob

Hwang, Sun-Hwi

Jin, Sung-Ho

Lee, Sang Eok

Lee, Yong-Joon

Seo, Kyung Won

Park, Sungsoo

Lee, Chang Min

Kim, Chang Hyun

Jeong, In Ho

Lee, Han Hong

Choi, Sung Il

Lee, Sang-Il

Kim, Chan Young

Chae, Hyundong

Son, Myoung-Won

Pak, Kyung Ho

Kim, Sungsoo

Lee, Moon-Soo

Min, Jae-Seok https://orcid.org/0000-0002-5798-4595
Funding

Funding for this research was provided by:

Korean Gastric Cancer Association, Republic of Korea (grant KGC0118C1)
License Information

Text and Data Mining valid from 2021-01-10

Version of Record valid from 2021-01-10
More Information

Article History

Received: 6 July 2020

Accepted: 1 December 2020

First Online: 10 January 2021

Disclosure

: There are no conflicts of interest.

Document is current

Any future updates will be listed below